Bone Morphogenetic Proteins and articular cartilage. To serve and protect or a wolf in sheep clothing's?

Osteoarthritis and Cartilage

Volumn 18, Issue 6, 2010, Pages 735-741

  van der Kraan, P M ^a   Blaney Davidson, E N ^a   van den Berg, W B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BMPs; Chondrocyte differentiation; MMP 13; Osteoarthritis

Indexed keywords

BONE MORPHOGENETIC PROTEIN; COLLAGENASE 3;

APOPTOSIS; ARTICULAR CARTILAGE; BONE DEVELOPMENT; CELL ACTIVITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SIZE; CELL STIMULATION; CHONDROGENESIS; CHONDROPATHY; DISEASE COURSE; ENCHONDRAL OSSIFICATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; GROWTH PLATE; HOMEOSTASIS; HUMAN; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

BONE MORPHOGENETIC PROTEINS; CARTILAGE, ARTICULAR; CELL COMMUNICATION; CELL DIFFERENTIATION; CHONDROCYTES; HOMEOSTASIS; HUMANS; OSTEOARTHRITIS;

EID: 77952878627     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.03.001     Document Type: Review

References (86)

1. Urist M.R. Bone: formation by autoinduction. Science 1965, 150(698):893-899.
2. Newfeld S.J., Wisotzkey R.G., Kumar S. Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers. Genetics 1999, 152(2):783-795.
3. Chang H., Brown C.W., Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002, 23(6):787-823.
4. Sengle G., Ono R.N., Lyons K.M., Bachinger H.P., Sakai L.Y. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J Mol Biol 2008, 381(4):1025-1039.
5. Yano K., Hoshino M., Ohta Y., Manaka T., Naka Y., Imai Y., et al. Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing. J Bone Miner Metab 2009, 27(3):355-363.
6. Ohta H., Wakitani S., Tensho K., Horiuchi H., Wakabayashi S., Saito N., et al. The effects of heat on the biological activity of recombinant human bone morphogenetic protein-2. J Bone Miner Metab 2005, 23(6):420-425.
7. Lavery K., Swain P., Falb D., Aoui-Ismaili M.H. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem 2008, 283(30):20948-20958.
8. Aono A., Hazama M., Notoya K., Taketomi S., Yamasaki H., Tsukuda R., et al. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 1995, 210(3):670-677.
9. van der Zee M., da Fonseca R.N., Roth S. TGFbeta signaling in Tribolium: vertebrate-like components in a beetle. Dev Genes Evol 2008, 218(3-4):203-213.
10. Ge G., Greenspan D.S. Developmental roles of the BMP1/TLD metalloproteinases. Birth Defects Res C Embryo Today 2006, 78(1):47-68.
11. Hopkins D.R., Keles S., Greenspan D.S. The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol 2007, 26(7):508-523.
12. Monzen K., Hiroi Y., Kudoh S., Akazawa H., Oka T., Takimoto E., et al. Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation. J Cell Biol 2001, 153(4):687-698.
13. Shibuya H., Iwata H., Masuyama N., Gotoh Y., Yamaguchi K., Irie K., et al. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J 1998, 17(4):1019-1028.
14. Nohno T., Ishikawa T., Saito T., Hosokawa K., Noji S., Wolsing D.H., et al. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 1995, 270(38):22522-22526.
15. Liu F., Ventura F., Doody J., Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 1995, 15(7):3479-3486.
16. Scharpfenecker M., van D.M., Liu Z., van Bezooijen R.L., Zhao Q., Pukac L., et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 2007, 120(Pt 6):964-972.
17. David L., Mallet C., Mazerbourg S., Feige J.J., Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007, 109(5):1953-1961.
18. de Sousa Lopes S.M., Roelen B.A., Monteiro R.M., Emmens R., Lin H.Y., Li E., et al. BMP signaling mediated by ALK2 in the visceral endoderm is necessary for the generation of primordial germ cells in the mouse embryo. Genes Dev 2004, 18(15):1838-1849.
19. Zhang D., Schwarz E.M., Rosier R.N., Zuscik M.J., Puzas J.E., O'Keefe R.J. ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res 2003, 18(9):1593-1604.
20. Nohe A., Keating E., Underhill T.M., Knaus P., Petersen N.O. Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways. J Cell Sci 2003, 116(Pt 16):3277-3284.
21. Gupta I.R., Macias-Silva M., Kim S., Zhou X., Piscione T.D., Whiteside C., et al. BMP-2/ALK3 and HGF signal in parallel to regulate renal collecting duct morphogenesis. J Cell Sci 2000, 113(Pt 2):269-278.
22. Xia Y., Babitt J.L., Sidis Y., Chung R.T., Lin H.Y. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 2008, 111(10):5195-5204.
23. Mazerbourg S., Hsueh A.J. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands. Hum Reprod Update 2006, 12(4):373-383.
24. Goldring M.B., Tsuchimochi K., Ijiri K. The control of chondrogenesis. J Cell Biochem 2006, 97(1):33-44.
25. Chimal-Monroy J., Rodriguez-Leon J., Montero J.A., Ganan Y., Macias D., Merino R., et al. Analysis of the molecular cascade responsible for mesodermal limb chondrogenesis: Sox genes and BMP signaling. Dev Biol 2003, 257(2):292-301.
26. Pan Q., Yu Y., Chen Q., Li C., Wu H., Wan Y., et al. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. J Cell Physiol 2008, 217(1):228-241.
27. Pan Q., Wu Y., Lin T., Yao H., Yang Z., Gao G., et al. Bone morphogenetic protein-2 induces chromatin remodeling and modification at the proximal promoter of Sox9 gene. Biochem Biophys Res Commun 2009, 379(2):356-361.
28. Pizette S., Niswander L. BMPs are required at two steps of limb chondrogenesis: formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev Biol 2000, 219(2):237-249.
29. Zhang W., Green C., Stott N.S. Bone morphogenetic protein-2 modulation of chondrogenic differentiation in vitro involves gap junction-mediated intercellular communication. J Cell Physiol 2002, 193(2):233-243.
30. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22(4):233-241.
31. Erickson D.M., Harris S.E., Dean D.D., Harris M.A., Wozney J.M., Boyan B.D., et al. Recombinant bone morphogenetic protein (BMP)-2 regulates costochondral growth plate chondrocytes and induces expression of BMP-2 and BMP-4 in a cell maturation-dependent manner. J Orthop Res 1997, 15(3):371-380.
32. Mailhot G., Yang M., Mason-Savas A., Mackay C.A., Leav I., Odgren P.R. BMP-5 expression increases during chondrocyte differentiation in vivo and in vitro and promotes proliferation and cartilage matrix synthesis in primary chondrocyte cultures. J Cell Physiol 2008, 214(1):56-64.
33. Minina E., Wenzel H.M., Kreschel C., Karp S., Gaffield W., McMahon A.P., et al. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 2001, 128(22):4523-4534.
34. Haaijman A., D'Souza R.N., Bronckers A.L., Goei S.W., Burger E.H. OP-1 (BMP-7) affects mRNA expression of type I, II, X collagen, and matrix Gla protein in ossifying long bones in vitro. J Bone Miner Res 1997, 12(11):1815-1823.
35. Chubinskaya S., Segalite D., Pikovsky D., Hakimiyan A.A., Rueger D.C. Effects induced by BMPS in cultures of human articular chondrocytes: comparative studies. Growth Factors 2008, 26(5):275-283.
36. Zhao L., Li G., Zhou G.Q. SOX9 directly binds CREB as a novel synergism with the PKA pathway in BMP-2-induced osteochondrogenic differentiation. J Bone Miner Res 2009, 24(5):826-836.
37. Uusitalo H., Hiltunen A., Ahonen M., Gao T.J., Lefebvre V., Harley V., et al. Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing. J Bone Miner Res 2001, 16(10):1837-1845.
38. Retting K.N., Song B., Yoon B.S., Lyons K.M. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 2009, 136(7):1093-1104.
39. Hecht J., Seitz V., Urban M., Wagner F., Robinson P.N., Stiege A., et al. Detection of novel skeletogenesis target genes by comprehensive analysis of a Runx2(-/-) mouse model. Gene Expr Patterns 2007, 7(1-2):102-112.
40. Miyazono K., Maeda S., Imamura T. Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins. Oncogene 2004, 23(24):4232-4237.
41. Lian J.B., Stein J.L., Stein G.S., van Wijnen A.J., Montecino M., Javed A., et al. Runx2/Cbfa1 functions: diverse regulation of gene transcription by chromatin remodeling and co-regulatory protein interactions. Connect Tissue Res 2003, 44(Suppl 1):141-148.
42. Leboy P., Grasso-Knight G., D'Angelo M., Volk S.W., Lian J.V., Drissi H., et al. Smad-Runx interactions during chondrocyte maturation. J Bone Joint Surg Am 2001, 83-A(Suppl 1(Pt 1)):S15-S22.
43. Leboy P.S. Regulating bone growth and development with bone morphogenetic proteins. Ann N Y Acad Sci 2006, 1068:14-18.
44. Javed A., Bae J.S., Afzal F., Gutierrez S., Pratap J., Zaidi S.K., et al. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 2008, 283(13):8412-8422.
45. Javed A., Afzal F., Bae J.S., Gutierrez S., Zaidi K., Pratap J., et al. Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation. Cells Tissues Organs 2009, 189(1-4):133-137.
46. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008, 2(1):1-13.
47. Xiao Y.T., Xiang L.X., Shao J.Z. Bone morphogenetic protein. Biochem Biophys Res Commun 2007, 362(3):550-553.
48. Chubinskaya S., Hurtig M., Rueger D.C. OP-1/BMP-7 in cartilage repair. Int Orthop 2007, 31(6):773-781.
49. Reddi A.H. Cartilage morphogenetic proteins: role in joint development, homoeostasis, and regeneration. Ann Rheum Dis 2003, 62(Suppl 2):ii73-ii78.
50. Chen A.L., Fang C., Liu C., Leslie M.P., Chang E., Di Cesare P.E. Expression of bone morphogenetic proteins, receptors, and tissue inhibitors in human fetal, adult, and osteoarthritic articular cartilage. J Orthop Res 2004, 22(6):1188-1192.
51. Bobacz K., Gruber R., Soleiman A., Erlacher L., Smolen J.S., Graninger W.B. Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. Arthritis Rheum 2003, 48(9):2501-2508.
52. Nakase T., Miyaji T., Tomita T., Kaneko M., Kuriyama K., Myoui A., et al. Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. Osteoarthritis Cartilage 2003, 11(4):278-284.
53. Fukui N., Zhu Y., Maloney W.J., Clohisy J., Sandell L.J. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 2003, 85-A(Suppl 3):59-66.
54. Dell'Accio F., De B.C., El Tawil N.M., Barone F., Mitsiadis T.A., O'Dowd J., et al. Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res Ther 2006, 8(5):R139.
55. Reddi A.H. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN. Arthritis Res 2001, 3(1):1-5.
56. Lories R.J., Daans M., Derese I., Matthys P., Kasran A., Tylzanowski P., et al. Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum 2006, 54(6):1736-1746.
57. Blaney Davidson E.N., Vitters E.L., van Lent P.L., van de Loo F.A., van den Berg W.B., van der Kraan P.M. Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling. Arthritis Res Ther 2007, 9(5):R102.
58. Tardif G., Hum D., Pelletier J.P., Boileau C., Ranger P., Martel-Pelletier J. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 2004, 50(8):2521-2530.
59. Tardif G., Pelletier J.P., Boileau C., Martel-Pelletier J. The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: an immunohistochemical study. Osteoarthritis Cartilage 2009, 17(2):263-270.
60. Kaiser M., Haag J., Soder S., Bau B., Aigner T. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta. Arthritis Rheum 2004, 50(11):3535-3540.
61. Uusitalo H., Hiltunen A., Soderstrom M., Aro H.T., Vuorio E. Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int 2000, 67(5):382-390.
62. Wang Y., Middleton F., Horton J.A., Reichel L., Farnum C.E., Damron T.A. Microarray analysis of proliferative and hypertrophic growth plate zones identifies differentiation markers and signal pathways. Bone 2004, 35(6):1273-1293.
63. Inada M., Wang Y., Byrne M.H., Rahman M.U., Miyaura C., Lopez-Otin C., et al. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci U S A 2004, 101(49):17192-17197.
64. Wu W., Billinghurst R.C., Pidoux I., Antoniou J., Zukor D., Tanzer M., et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 2002, 46(8):2087-2094.
65. Tchetina E.V., Squires G., Poole A.R. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 2005, 32(5):876-886.
66. Shen B., Wei A., Tao H., Diwan A.D., Ma D.D. BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng Part A 2009, 15(6):1311-1320.
67. Wu X., Shi W., Cao X. Multiplicity of BMP signaling in skeletal development. Ann N Y Acad Sci 2007, 1116:29-49.
68. Kobayashi T., Lyons K.M., McMahon A.P., Kronenberg H.M. BMP signaling stimulates cellular differentiation at multiple steps during cartilage development. Proc Natl Acad Sci U S A 2005, 102(50):18023-18027.
69. Sakano S., Murata Y., Miura T., Iwata H., Sato K., Matsui N., et al. Collagen and alkaline phosphatase gene expression during bone morphogenetic protein (BMP)-induced cartilage and bone differentiation. Clin Orthop Relat Res 1993, 292:337-344.
70. Chen P., Carrington J.L., Hammonds R.G., Reddi A.H. Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor beta 1 and beta 2. Exp Cell Res 1991, 195(2):509-515.
71. Horiki M., Imamura T., Okamoto M., Hayashi M., Murai J., Myoui A., et al. Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia. J Cell Biol 2004, 165(3):433-445.
72. Li X., Ionescu A.M., Schwarz E.M., Zhang X., Drissi H., Puzas J.E., et al. Smad6 is induced by BMP-2 and modulates chondrocyte differentiation. J Orthop Res 2003, 21(5):908-913.
73. Fan Z., Chubinskaya S., Rueger D.C., Bau B., Haag J., Aigner T. Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1. Clin Exp Rheumatol 2004, 22(1):103-106.
74. Majumdar M.K., Chockalingam P.S., Bhat R.A., Sheldon R., Keohan C., Blanchet T., et al. Immortalized mouse articular cartilage cell lines retain chondrocyte phenotype and respond to both anabolic factor BMP-2 and pro-inflammatory factor IL-1. J Cell Physiol 2008, 215(1):68-76.
75. Hou C.H., Hsiao Y.C., Fong Y.C., Tang C.H. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Bone 2009, 44(2):233-242.
76. Varghese S., Rydziel S., Canalis E. Bone morphogenetic protein-2 suppresses collagenase-3 promoter activity in osteoblasts through a runt domain factor 2 binding site. J Cell Physiol 2005, 202(2):391-399.
77. Varghese S., Canalis E. Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures. Endocrinology 1997, 138(3):1035-1040.
78. Nakashima A., Tamura M. Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation. Front Biosci 2006, 11:1667-1678.
79. Krawczak D.A., Westendorf J.J., Carlson C.S., Lewis J.L. Influence of bone morphogenetic protein-2 on the extracellular matrix, material properties, and gene expression of long-term articular chondrocyte cultures: loss of chondrocyte stability. Tissue Eng Part A 2009, 15(6):1247-1255.
80. Aigner T., Fundel K., Saas J., Gebhard P.M., Haag J., Weiss T., et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 2006, 54(11):3533-3544.
81. Aigner T., Zien A., Gehrsitz A., Gebhard P.M., McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001, 44(12):2777-2789.
82. Hermansson M., Sawaji Y., Bolton M., Alexander S., Wallace A., Begum S., et al. Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin betaA (activin A), a regulatory molecule for chondrocytes. J Biol Chem 2004, 279(42):43514-43521.
83. Gamer L.W., Ho V., Cox K., Rosen V. Expression and function of BMP3 during chick limb development. Dev Dyn 2008, 237(6):1691-1698.
84. Allendorph G.P., Isaacs M.J., Kawakami Y., Belmonte J.C., Choe S. BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors. Biochemistry 2007, 46(43):12238-12247.
85. Blaney Davidson E.N., Vitters E.L., van der Kraan P.M., van den Berg W.B. Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis 2006, 65(11):1414-1421.
86. Blaney Davidson E.N., Remst D.F., Vitters E.L., van Beuningen H.M., Blom A.B., Goumans M.J., et al. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 2009, 182(12):7937-7945.